
Lipocine Inc.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Lipocine Inc. is a pharmaceutical company developing oral drug products based on its proprietary oral delivery technologies, with a focus on men's and women's health conditions such as testosterone deficiency and other hormone-related disorders.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Higuchi John W.Director | Buy | $36K | 15,970at $2.23 | Sep 30, 2026 |
| Higuchi John W.Director | Buy | $19K | 9,037at $2.15 | Sep 29, 2026 |
| Higuchi John W.Director | Buy | $27K | 12,561at $2.16 | Sep 28, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable LPCN activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.